5月14日周三，Apellis Pharmaceuticals（股票代码：APLS）股价盘中大跌5.03%，引发市场关注。
导致股价下跌的主要原因是，瑞穗银行分析师大幅下调了Apellis Pharmaceuticals的目标价。根据最新研报，瑞穗将该公司的目标价从30美元下调至20美元，降幅达33.33%。
分析师的目标价调整往往会对投资者情绪产生显著影响。此次大幅下调目标价可能反映出分析师对公司未来业绩增长的担忧，从而引发了市场抛售。需要注意的是，目前观察到的是盘中走势，收盘价格可能会有所变化。
投资者可能需要密切关注Apellis Pharmaceuticals未来的业务发展和财务状况，以评估公司的长期投资价值。同时，也应该关注其他分析师的观点，全面了解市场对该股票的看法。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.